MedPath

THINK Surgical's TMINI Robot Cleared by FDA for Use with LinkSymphoKnee Implants

• THINK Surgical's TMINI Miniature Robotic System received FDA 510(k) clearance for use with Waldemar Link GmbH & Co. KG's LinkSymphoKnee (LSK) implants, expanding its application in knee replacement surgery. • The collaboration integrates LinkSymphoKnee into THINK Surgical's ID-HUB, offering surgeons a cost-effective, precise, hand-held robotic solution for primary knee replacement procedures. • The TMINI system now supports eight different knee implant designs from various orthopedic companies, providing surgeons with a range of options within a single robotic platform.

THINK Surgical, Inc. has announced that its TMINI Miniature Robotic System received FDA 510(k) clearance for use with the LinkSymphoKnee (LSK) implants from Waldemar Link GmbH & Co. KG (LINK). This clearance expands the utility of the TMINI system in primary knee replacement surgeries, offering surgeons a precise and adaptable tool.
The LinkSymphoKnee implant has been integrated into THINK Surgical’s ID-HUB, a database of implant modules compatible with the open platform version of the TMINI System in the United States. This integration provides surgeons with a cost-effective, hand-held robotic option that complements the LinkSymphoKnee primary products.
"Through this partnership, we’re not only providing a state-of-the-art robotic solution but a nimble, cost-effective, hand-held option that complements the full spectrum of our LinkSymphoKnee primary products," said Greg Pomasl, president of LINK in the USA (LinkBio Corporation).
Stuart Simpson, president and CEO of THINK Surgical, stated, "THINK Surgical is excited to add the LinkSymphoKnee to the TMINI System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic, and guided motion knees on a single robotic platform."
The TMINI system aims to enhance surgical precision and improve patient outcomes in knee replacement procedures. The collaboration between THINK Surgical and Waldemar Link GmbH & Co. KG seeks to provide surgeons with advanced tools for delivering exceptional patient care.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Maxx Orthopedics Gains FDA Clearance for Medial Congruent Insert in Total Knee Arthroplasty

Maxx Orthopedics has received FDA clearance for its medial congruent insert designed for use with the Freedom total knee arthroplasty system.
The new insert aims to replicate natural knee kinematics and enhance medial stability for patients undergoing total knee arthroplasty.

Corin's Icona Femoral Stem Receives FDA Clearance for Direct Anterior Total Hip Arthroplasty

Corin has obtained FDA 510(k) clearance for its Icona femoral stem, designed for direct anterior total hip arthroplasty, facilitating use in ambulatory surgery centers.
The Icona femoral stem is a collared, metaphyseal-filling, triple-taper design, developed using data from the CorinRegistry for enhanced performance.

Exactech Receives FDA Clearance for Truliant Porous 3D Tibial Knee Implant

Exactech's Truliant porous 3D tibial tray received FDA 510(k) clearance, marking a significant advancement in cementless knee replacement solutions.
The implant utilizes additive manufacturing to create a porous structure that mimics cancellous bone, promoting initial and biological fixation for active patients.

L&K Biomed's BluEX Lumbar Expandable Cage System Receives FDA Approval

L&K Biomed secured FDA 510(k) clearance for its BluEX Lumbar Expandable Cage System, designed for enhanced bone integration and versatile surgical approaches.
The BluEX system features six cage designs adaptable for anterior, posterior, lateral, ATP, and endoscopic lumbar approaches, offering surgeons greater flexibility.

Catalyst OrthoScience's Shoulder Fracture System Receives FDA Clearance

Catalyst OrthoScience has received FDA 510(k) clearance for its innovative shoulder fracture system, expanding its comprehensive orthopedic portfolio.
The Catalyst fracture system is specifically designed for reverse shoulder arthroplasty in patients suffering from proximal humerus fractures.

Corin's Unity Knee Medial Constrained Tibial Insert Receives FDA Clearance for TKA

Corin has received FDA 510(k) clearance for its Unity Knee medial constrained tibial insert, designed for both standard and robotic-assisted total knee arthroplasty (TKA).
The Unity Knee MC insert is compatible with Corin's ApolloKnee robotic platform, allowing surgeons to stabilize the medial compartment during TKA procedures.

Regenity Biosciences' RejuvaKnee Implant Receives FDA Clearance for Meniscal Repair

Regenity Biosciences has received FDA 510(k) clearance for RejuvaKnee, a regenerative implant for soft tissue injuries of the meniscus, offering a minimally invasive, collagen-based approach.
Animal studies demonstrated that RejuvaKnee facilitated significant tissue regeneration, allowing full weight bearing within three months, surpassing outcomes of meniscectomy and allograft transplantation.

FDA Clears Think Surgical's TMINI Robotic System for Medacta Knee Implants

Think Surgical's TMINI robotic system has received FDA 510(k) clearance for use with Medacta's GMK Sphere and SpheriKA knee systems, expanding robotic-assisted TKA options.
The collaboration between Think Surgical and Medacta aims to integrate robotic surgery platforms with advanced knee implant systems for personalized solutions.

THINK Surgical's TMINI Robot Cleared for Zimmer Biomet's Persona Knee System

THINK Surgical received FDA 510(k) clearance for its TMINI robotic system to be used with Zimmer Biomet's Persona Knee System, expanding surgical options.
The TMINI system features a wireless, handheld design intended to enhance precision in total knee replacement procedures, particularly in outpatient settings.

SI-BONE's iFuse TORQ TNT Implant System Receives FDA Clearance for Pelvic Fragility Fractures

SI-BONE's iFuse TORQ TNT implant system has received FDA 510(k) clearance, offering a novel solution for pelvic fragility fractures.
The TNT system is designed to address the specific anatomical and bone mineral density needs of the sacrum and ilium, potentially improving treatment outcomes.

Reference News

[1]
THINK Surgical Receives FDA 510(k) Clearance for Use of LinkSymphoKnee (LSK ...
orthospinenews.com · Nov 18, 2024

THINK Surgical's TMINI Miniature Robotic System receives FDA 510(k) clearance for use with LINK's LinkSymphoKnee, expand...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy